300 related articles for article (PubMed ID: 36877677)
41. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
42. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
[TBL] [Abstract][Full Text] [Related]
43. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
[TBL] [Abstract][Full Text] [Related]
44. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023.
Montoy JCC; Ford J; Yu H; Gottlieb M; Morse D; Santangelo M; O'Laughlin KN; Schaeffer K; Logan P; Rising K; Hill MJ; Wisk LE; Salah W; Idris AH; Huebinger RM; Spatz ES; Rodriguez RM; Klabbers RE; Gatling K; Wang RC; Elmore JG; McDonald SA; Stephens KA; Weinstein RA; Venkatesh AK; Saydah S;
MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(32):859-865. PubMed ID: 37561663
[TBL] [Abstract][Full Text] [Related]
46. Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydah S; Block JP;
BMC Infect Dis; 2024 Feb; 24(1):181. PubMed ID: 38341566
[TBL] [Abstract][Full Text] [Related]
47. Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study.
Haghi Ashtiani MT; Sadeghi Rad P; Asnaashari K; Shahhosseini A; Berenji F; Mamishi S
PLoS One; 2022; 17(4):e0266923. PubMed ID: 35421183
[TBL] [Abstract][Full Text] [Related]
48. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
49. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
[TBL] [Abstract][Full Text] [Related]
50. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
Ballering AV; van Zon SKR; Olde Hartman TC; Rosmalen JGM;
Lancet; 2022 Aug; 400(10350):452-461. PubMed ID: 35934007
[TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
[TBL] [Abstract][Full Text] [Related]
54. 'Long COVID': Symptom persistence in children hospitalised for COVID-19.
Asadi-Pooya AA; Nemati M; Nemati H
J Paediatr Child Health; 2022 Oct; 58(10):1836-1840. PubMed ID: 35851732
[TBL] [Abstract][Full Text] [Related]
55. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
[TBL] [Abstract][Full Text] [Related]
56. Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System.
Malden DE; Tartof SY; Ackerson BK; Hong V; Skarbinski J; Yau V; Qian L; Fischer H; Shaw SF; Caparosa S; Xie F
JMIR Public Health Surveill; 2022 Dec; 8(12):e41529. PubMed ID: 36446133
[TBL] [Abstract][Full Text] [Related]
57. Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.
Looker KJ; McClenaghan E; Judd A; Pierotti L; Downing H; Phelan J; Warren-Gash C; Ngozi K; Dawe F; Relton C; Christensen H; Hay AD; Mangtani P; Nguipdop-Djomo P; Denholm R
PLoS One; 2024; 19(5):e0303892. PubMed ID: 38776311
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study.
Hetlevik Ø; Wensaas KA; Baste V; Emberland KE; Özgümüs T; Håberg SE; Rortveit G
BMC Infect Dis; 2023 Oct; 23(1):721. PubMed ID: 37880583
[TBL] [Abstract][Full Text] [Related]
59. Symptoms and quality of life before, during, and after a SARS-CoV-2 PCR positive or negative test: data from Lifelines.
Goërtz YMJ; Spruit MA; Van Herck M; Dukers-Muijrers N; ; van der Kallen CJH; Burtin C; Janssen DJA
Sci Rep; 2023 Jul; 13(1):11713. PubMed ID: 37474524
[TBL] [Abstract][Full Text] [Related]
60. Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
Davisse-Paturet C; Orri M; Legleye S; Florence AM; Hazo JB; Warszawski J; Falissard B; Geoffroy MC; Melchior M; Rouquette A;
PLoS Med; 2023 Feb; 20(2):e1004171. PubMed ID: 36787340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
